Short description
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Description
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs.Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2006
Closed on
May 24, 2022
Exited on
February 6, 2014
Went public on
February 6, 2014
Stock symbol
GNCA
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$34056 - 789030
Sign in for full access
Investors
No Way, Absolutely Noaccess, Cannot Access, Cannot Access, Nopepepe, Noaccessforu, Noaccess, Noaccessforu, Cannot Access, Noaccess, Noway Youcantaccess, Noaccessforu, Blurry Noaccess
Sign in for full access
Founders
Chip Clark, Darren Higgins, David Sinclair, Josh Wolfe, Kevin Bitterman